BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 11222523)

  • 1. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A; English RV; Nadelstein B
    Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
    Gao J; Schwalb TA; Addeo JV; Ghosn CR; Stern ME
    Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
    Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B; Farley W; Stern ME; Pflugfelder SC
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C; Celik I; Alkan F; Erol M; Sur E
    Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
    Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
    J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival effects of canine distemper virus-induced keratoconjunctivitis sicca.
    de Almeida DE; Roveratti C; Brito FL; Godoy GS; Duque JC; Bechara GH; Laus JL
    Vet Ophthalmol; 2009; 12(4):211-5. PubMed ID: 19604335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a rabbit model for keratoconjunctivitis sicca.
    Chen ZY; Liang QF; Yu GY
    Cornea; 2011 Sep; 30(9):1024-9. PubMed ID: 21659853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
    Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
    Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O; Baudouin C; Pisella PJ; Brignole F
    J Fr Ophtalmol; 2003 Apr; 26(4):337-43. PubMed ID: 12843889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
    J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of HL036 versus Cyclosporine A in the Treatment of Naturally Occurring Canine Keratoconjunctivitis Sicca.
    Lee HB; Choi HJ; Cho SM; Kang S; Ahn HK; Song YJ; Kim YJ; Son WC
    Curr Eye Res; 2018 Jul; 43(7):889-895. PubMed ID: 29634381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
    Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
    Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study.
    Nell B; Walde I; Billich A; Vit P; Meingassner JG
    Vet Ophthalmol; 2005; 8(1):39-46. PubMed ID: 15644099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.